West Nile virus

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Background

Virolgy

  • RNA virus
  • Virus family associated with St Louise encephalitis, Japanese encephalitis, Murray Vallen enceph, and Kunjin enceph
  • 2 lineage of WNV - only lineage 1 associated with human disease originating in Middle East/Israel

Ecology

  • Bird- mosquito- bird cycle
  • Passerine birds are amplification host
  • Starts in spring, ends in fall when mosquitos dormant
  • Culex mosquitos
  • Unclear if human infection from culex bite or other bridge vector mosquito species
  • House sparrows have high level of viremia and are amplifiers
  • Humans and horses also but viremia is low so are not important amplifiers
  • WNV in birds feces and oral secretions
  • Bird to bird transmission possible in lab
  • Birds can be infected by eating infected mosquitoes, birds or odents but importance of oral spread in nature unclear

Epidemiology

Global Distribution of West Nile Virus. Source: CDC
  • Found in Africa, Middle East, Russia, Australia
  • First appeared in eastern US in 1999 but now found nationwide[1]
  • Most human infections occur in August and Sept but can happen from May to Dec
  • Human Transmission
    • Most from mosquito bites
    • Maternal fetal
    • Breast milk
    • Blood transfusion
    • Percutaneous lab infection

Clinical Features

  • Most people asymptomatic
  • Severity increases with age
  • 2-14 day incubation
  • Illness for 3-6 days
  • Malaise, anorexia, nausea/vomiting, eye pain, headache, myalgia, rash
  • 20% of infected patients get West Nile fever
  • <1% get severe neuro problem- encephalitis, meningitis, acute flaccid paralysis
  • Can also get movement disorder- tremor, myoclonus, Parkinsonism, bradykinesia
  • Can also have cranial nerve involvement, optic neuritis, seizure
  • Myocarditis, pancreatitis, fulminant hepatitis
  • Acute flaccid paralysis
    • Weakness can affect upper or lower limbs and can happen without meningitis
    • Can become hypo/areflexic, acute bowel and bladder dysfunction, absence of pain, or sensory changes
    • CSF has increased protein and pleocytosis
    • Similar to polio with destruction of spinal anterior horn cells as opposed to GBS

Differential Diagnosis

Altered mental status and fever

Evaluation

  • WBC count normal or slightly elevated
  • CSF - pleocytosis with lymphocyte predominance and elevated protein
  • CT head- negative
  • MRI brain usually negative but can show focal lesion in pons, basal gang, thal
  • Confirmation by blood or CSF IgM
    • IgM does not cross BBB so CSF IgM indicated CNS infc
  • False positive is recently vaccinated for yellow fever, Jap enceph, or recently infected with relate flavivirus- St Louse, Dengue
  • Confirmation by 4X increase of acute/ conv titres of antibodies

Management

  • Supportive
  • No studies to support ribavirin, interferon, gamma globulin, steroids, anticonvulsants, or osmotic agents

Prognosis

  • 4- 18% fatality
  • Older age greatest risk for death
  • Risk for poor neuro outcome and death- encephalitis, severe muscle weakness, AMS, DM, immune suppression
  • Can have significant morbidity and loss of function even in those patients that survive and are discharged to home
  • Parkinsons, tremor, gait instability, balance problems are most common neuro findings after discharge to home
  • Initial severe encephalopathy did not mean poor neuro outcome
  • Acute flaccid paralysis typically has very poor recovery

Disposition

Admit

External Links

https://www.cdc.gov/westnile/index.html

See Also

References

  1. West Nile virus. Centers for Disease Control and Prevention website. Accessed January 15, 2021.